These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2404120)

  • 1. Cephalosporins to carbapenems: 1-oxygenated carbapenems and carbapenams.
    Rosati RL; Kapili LV; Morrissey P; Retsema JA
    J Med Chem; 1990 Jan; 33(1):291-7. PubMed ID: 2404120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.
    Hakimelahi GH; Moosavi-Movahedi AA; Saboury AA; Osetrov V; Khodarahmi GA; Shia KS
    Eur J Med Chem; 2005 Apr; 40(4):339-49. PubMed ID: 15804533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial evaluation of novel 2-[N-Imidoylpyrrolidinyl] carbapenems.
    Hattori K; Yamada A; Kuroda S; Chiba T; Murata M; Sakane K
    Bioorg Med Chem Lett; 2002 Feb; 12(3):383-6. PubMed ID: 11814802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
    Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
    Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
    Netikul T; Leelaporn A; Leelarasmee A; Kiratisin P
    Int J Antimicrob Agents; 2010 Jun; 35(6):609-10. PubMed ID: 20189774
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.
    Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M
    Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems.
    Mastalerz H; Menard M; Ruediger E; Fung-Tomc J
    J Med Chem; 1992 Mar; 35(5):953-8. PubMed ID: 1548685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum].
    Cavallo JD; Fabre R; Crenn Y; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):365-8. PubMed ID: 7824297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
    Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
    Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
    Rai R; Chen HN; Czyryca PG; Li J; Chang CW
    Org Lett; 2006 Mar; 8(5):887-9. PubMed ID: 16494466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compounds.
    Imamura H; Ohtake N; Shimizu A; Jona H; Sato H; Nagano R; Ushijima R; Yamada K; Hashizume T; Morishima H
    Bioorg Med Chem Lett; 2000 Jan; 10(2):109-13. PubMed ID: 10673091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
    Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
    J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrier-Petasis rearrangement of 4-(vinyloxy)azetidin-2-ones: an entry to carbapenams and carbacephams.
    Kozioł A; Grzeszczyk B; Kozioł A; Staszewska-Krajewska O; Furman B; Chmielewski M
    J Org Chem; 2010 Oct; 75(20):6990-3. PubMed ID: 20853897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
    Jean SS; Lee WS; Bai KJ; Yu KW; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):290-5. PubMed ID: 25600841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biosynthetic implications of acetate and glutamate incorporation into (3R,5R)-carbapenam-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic acid by Serratia sp.
    Bycroft BW; Maslen C; Box SJ; Brown A; Tyler JW
    J Antibiot (Tokyo); 1988 Sep; 41(9):1231-42. PubMed ID: 3182403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.